Kenneth C. Frazier

2014

In 2014, Kenneth C. Frazier earned a total compensation of $25M as Chairman, President and Chief Executive Officer at Merck & Co., a 87% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$3,642,161
Non-Equity Incentive Plan$3,341,250
Option Awards$3,323,244
Salary$1,500,000
Stock Awards$13,025,313
Other$197,402
Total$25,029,370

Frazier received $13M in stock awards, accounting for 52% of the total pay in 2014.

Frazier also received $3.6M of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $3.3M in option awards, $1.5M in salary and $197.4K in other compensation.

Rankings

In 2014, Kenneth C. Frazier's compensation ranked 78th out of 13,032 executives tracked by ExecPay. In other words, Frazier earned more than 99.4% of executives.

ClassificationRankingPercentile
All
78
out of 13,032
99th
Division
Manufacturing
28
out of 4,966
99th
Major group
Chemicals And Allied Products
13
out of 1,686
99th
Industry group
Drugs
12
out of 1,365
99th
Industry
Pharmaceutical Preparations
12
out of 1,043
99th
Source: SEC filing on April 10, 2017.

Frazier's colleagues

We found five more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2014.

2014

Robert Davis

Merck & Co.

Chief Financial Officer

2014

Adam Schechter

Merck & Co.

Executive Vice President and President, Global Human Health

2014

Roger Perlmutter

Merck & Co.

Executive Vice President and President, Merck Research Laboratories

2014

Bruce Kuhlik

Merck & Co.

General Counsel

2014

Peter Kellogg

Merck & Co.

Chief Financial Officer

News

You may also like